Panadol, the flagship brand of GlaxoSmithKline, today launched a nationwide campaign to raise public awareness on post COVID-19 vaccination care for pain and fever. In support of the Government’s effort to combat vaccine hesitancy amongst the community and increase vaccination uptake, the Panadol Post COVID-19 Vaccination campaign will include pertinent tips and information on how to manage post COVID-19 vaccination pain and fever with Panadol. Bryan Wong, General Manager of GSK Consumer Healthcare Malaysia, said, "The government’s pledge to vaccinate at least 80% of Malaysia’s adult population by February 2022 has our full support. It is encouraging to see a high rate of acceptance of the COVID-19 vaccines in Malaysia and the vaccination rate has been climbing steadily. To achieve the herd immunity target as soon as possible, it is not only important for us to play a part in educating the public about the importance of COVID-19 vaccination; but also provide accurate guidance, on
